ISRCTN84780767已完成不适用
Improving parenchymal phase imaging of the pancreas with multidetector CT using experience from dynamic contrast enhanced MR studies.
Record Provided by the NHSTCT Register - 2006 Update - Department of Health0 个研究点目标入组 60 人开始时间: 2006年9月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age over 18 - pancreatic adenocarcinoma is unusual below this age and children are more sensitive to additional ionising radiation than adults
- •2. Stage III ovarian cancer or colorectal cancer
- •3. Routine attendance for contrast enhanced abdominal CT - no patients not otherwise having CT and contrast will be approached.
排除标准
- •1. Severe local disease affecting pancreatic aorta/branches. This may introduce delays to the arrival of contrast due to compromise of arteries (SMA/Coeliac axis)
- •2. Major atherosclerotic disease of SMA/Coeliac axis - again, to avoid significant delay in contrast path distal to pancreatic aorta
- •3. Significant pancreatic resection - absence of normal pancreatic tissue will preclude our numerical assessment of enhancement
- •4. Pre-existing pancreatic disease - cancer or pancreatitis.
研究者
相似试验
已完成
不适用
Functional magnetic resonance imaging of pancreatic cancer: a feasibility and reproducibility study10019815pancreatic cancerNL-OMON41555Academisch Medisch Centrum30
已完成
不适用
aparoscopy-assisted (pylorus preserved) pancreatoduodenectomy for reduction of surgical invasivenessThe patient who receives pancreatoduodenectomyJPRN-UMIN000013282agasaki University Hospital80
已完成
不适用
Development of Diagnostic Imaging of Pancreatic Cancer using New PET Probe MePropancreatic cancerJPRN-jRCTs031210472Yamazaki Kana10
已完成
不适用
Development of Diagnostic Imaging of Pancreatic Cancer using New PET ProbePancreatic cancerJPRN-jRCTs031210074Yamazaki Kana10
招募中
2 期
Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)Pancreatic Ductal Adenocarcinoma (PDAC)NCT06659705Institut Curie35
